drugset / Trial / NCT01506843

Sublingual Immunotherapy in Children With Allergic Rhinitis

NCT01506843 ↗

RandomizedFactorialQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the clinical efficacy and mucosal/systemic antibody response changes after SLIT using house dust mite allergen with or without bacterial extracts in mite-allergic children.

Timeline

Start
2008-10
Primary completion
2010-10
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dpt allergen extract Unknown 36 ug Subcutaneous
Comparator mixed respiratory bacterial extracts Unknown — Subcutaneous

Indications